Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. able

ABLE SIGNED

Home use, affordable and lightweight exoskeleton for people with lower-limb paralysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ABLE project word cloud

Explore the words cloud of the ABLE project. It provides you a very rough idea of what is the project "ABLE" about.

innovative    independence    hospitals    injury    stakeholders    disruptive    device    egrave    spin    caixaimpulse    palliating    validate    independently    launch    acceleration    trl9    intention    centers    lower    lifestyle    intuitive    off    people    expensive    walk    richi    natural    caused    readiness    human    sensor    de    rehabilitation    movements    world    fit    medical    detects    electric    establishing    sedentary    team    150    possibility    boston    lightweight    programs    usa    actuator    home    business    vision    successful    healthcare    robotic    flexes    allowed    ups    health    upc    company    mobility    exoskeleton    leg    inertial    found    awarded    massmedic    patient    commercialize    patented    motion    newly    self    limb    plan    boosting    model    move    assist    first    movement    catalunya    affordable    professional    walking    eit    heavy    cnica    cimit    had    foundation    restores    helps    confidence    trained    supervision    start    polit    won    extends    universitat    trl    again    mimicking    everybody    accelerator    market    18    paralysis    timeframe    algorithms    restore    exoskeletons    medtech   

Project "ABLE" data sheet

The following table provides information about the project.

Coordinator		 ABLE HUMAN MOTION S.L. 

Organization address
address: SANT EUDALD 57 1 1
city: Barcelona
postcode: 8023
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.ablehumanmotion.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ABLE HUMAN MOTION S.L. ES (Barcelona) coordinator 50˙000.00

Map

 Project objective

People with lower-limb paralysis could walk again if they had a robotic exoskeleton to restore the leg movements affected by the injury. However, current devices are expensive (cost about 100 k€), heavy and require trained professional supervision. Therefore, they are only found in large hospitals and rehabilitation centers, and are out of the reach of the patient.

ABLE Human Motion is a medical device spin-off from Universitat Politècnica de Catalunya (UPC) that is developing and will commercialize robotic exoskeletons to enhance their mobility and independence. ABLE’s vision is to build a world where everybody has the possibility to move independently, with that aim we plan the launch of ABLE: the first home use, affordable and lightweight exoskeleton that restores the ability to walk of people with lower-limb paralysis in a natural and intuitive way. It is based on an electric actuator that flexes and extends the leg mimicking human natural movement, and an inertial sensor that together with dedicated algorithms detects the user’s intention to make the step forward. This patented and disruptive system to assist walking helps palliating health issues caused by sedentary lifestyle while boosting self-confidence and independence.

So far our newly established company has been awarded as an innovative technology to improve healthcare by CaixaImpulse and EIT Health. We have been selected among the 5 most promising medtech start-ups by MassMEDIC (Boston, USA). The team has also won the acceleration programs organized by Richi Foundation and CIMIT, the most successful health accelerator in the world. This has allowed us to validate the product-market fit with more than 150 stakeholders, establishing a viable business model and a go-to-market plan.

The project is currently at Technology Readiness Level (TRL) between 6 and 7, and should reach TRL9 within an 18-month timeframe.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABLE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABLE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More